ALOXI
Google image searchProduct monograph
Active ingredient
palonosetron (palonosetron hydrochloride), 0.25 MG/5 ML
DIN: 02381710
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Description: SINGLE USE VIAL
Schedule: Prescription
Company: KNIGHT THERAPEUTICS INC.
Date: 02-DEC-2022
ATC:
- A04 — ANTIEMETICS AND ANTINAUSEANTS (ATC, ATC/DDD, )
- A04A — ANTIEMETICS AND ANTINAUSEANTS (ATC, ATC/DDD)
- A04AA — Serotonin (5HT3) antagonists (ATC, ATC/DDD)
- A04AA05 — PALONOSETRON (ATC/DDD)
Reference brand drug: Aloxi
